VAUGHAN, Ontario, February 06, 2025--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better ...

January 31, 2024 US FDA warns consumers over copycats of Bausch + Lomb eye drops The U.S. Food and Drug Administration (FDA) on Wednesday warned consumers not to use unapproved eye drops that ...

Shares in ophthalmology specialist Bausch + Lomb (B+L) have lost almost 10% of ... intraocular lenses, and eye surgery products, and made revenues of $4.15 billion last year.

From the eye care experts at Bausch and Lomb, LUMIFY works in 1 minute and lasts up to 8 hours LUMIFY is different: The only OTC drop to contain brimonidine. It selectively targets redness ...

Bausch + Lomb Corporation (NYSE:BLCO; TSX:BLCO), a prominent player in the global eye health market with a market capitalization of $5.78 billion, has been navigating a complex landscape of ...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced an ...

Listen and subscribe to Opening Bid on Apple Podcasts, Spotify, YouTube, or wherever you find your favorite podcasts. After completing $300 billion in healthcare deals over several decades, there ...

VAUGHAN, Ontario (AP) — VAUGHAN, Ontario (AP) — Bausch + Lomb Corporation (BLCO) on Wednesday reported a loss of $3 million in its fourth quarter. On a per-share basis, the Vaughan ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders ...

(RTTNews) - Bausch + Lomb Corp. (BLCO), Wednesday announced the financial outlook, expecting revenue of $4.950 billion to $5.050 billion for the fiscal year 2025. Analysts, on average, estimates ...

(RTTNews) - Below are the earnings highlights for Bausch + Lomb Corporation (BLCO): Earnings: -$3 million in Q4 vs. -$54 million in the same period last year. EPS: -$0.01 in Q4 vs. -$0.15 in the ...